Anand Rathi Wealth Regulatory Approval

Annual General Meeting

Anand Rathi Wealth Annual General Meeting

Anand Rathi Wealth seeks shareholder approval via postal ballot for material related party transactions with Aligned Investment Private Limited and amendments to its Memorandum of Association.

Value

₹1,200 Cr

Annual General Meeting

Anand Rathi Wealth Annual General Meeting

Anand Rathi Wealth Limited issued a postal ballot notice to seek shareholder approval for altering its Objects Clause and for material related party transactions.

Earnings Call

Anand Rathi Wealth Earnings Call Transcript: Key Takeaways

Anand Rathi delivered consistent growth, beating PAT guidance despite market volatility. Management maintains a rigid pricing model with zero discounts for high-value clients.

Call

Guides 14% growth

Dividend

Anand Rathi Wealth Dividend

Anand Rathi Wealth Limited declared an interim dividend of ₹4 per equity share. The record date for the dividend payment is 15-10-2026.

Earnings Call

Anand Rathi Wealth Investor Presentation: Key Takeaways

Anand Rathi Wealth reported robust Q2FY27 performance with 16.1% revenue growth and 22.2% PAT growth, driven by increasing AUM and market share in equity mutual funds.

Financial Results

Anand Rathi Wealth Q2 FY27 Results: Net Profit ₹89.3 Cr, Down 10.6% YoY

Anand Rathi Wealth Ltd reported revenue from operations of ₹344 Cr (+15.7% YoY) and net profit of ₹89.3 Cr (-10.6% YoY) for Q2 FY27.

Key figure

Net profit ₹89.3 Cr · -10.6% YoY

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.